We are live on ! Find out more
NRC icon

NRC Health Common Stock

116 hedge funds and large institutions have $456M invested in NRC Health Common Stock in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 31

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

3% more funds holding

Funds holding: 113116 (+3)

0.82% more ownership

Funds ownership: 44.86%45.68% (+0.82%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $473M → $456M (-$17.1M)

Holders
116
Holders Change
+3
Holders Change %
+2.65%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
43
Reduced
31
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$598K +$23.8K +609 +4%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$566K +$1.06K +27 +0.2%
AG
53
Algert Global
California
$546K +$539K +13,760 New
ETC
54
Exchange Traded Concepts
Oklahoma
$525K +$10.2K +260 +2%
PPA
55
Parametric Portfolio Associates
Washington
$513K -$13.6K -348 -3%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$445K +$235 +6 +0.1%
Qube Research & Technologies (QRT)
57
Qube Research & Technologies (QRT)
United Kingdom
$438K +$83.9K +2,144 +24%
Deutsche Bank
58
Deutsche Bank
Germany
$388K -$43.7K -1,117 -10%
MIM
59
MetLife Investment Management
New Jersey
$375K +$127K +3,250 +52%
Victory Capital Management
60
Victory Capital Management
Texas
$374K +$36.3K +927 +9%
MAM
61
Martingale Asset Management
Massachusetts
$373K +$15.7K +400 +4%
M&T Bank
62
M&T Bank
New York
$352K +$348K +8,880 New
Citadel Advisors
63
Citadel Advisors
Florida
$343K -$571K -14,593 -63%
Envestnet Asset Management
64
Envestnet Asset Management
Illinois
$324K +$23.4K +599 +8%
Skandinaviska Enskilda Banken (SEB)
65
Skandinaviska Enskilda Banken (SEB)
Sweden
$309K
CPA
66
Cowen Prime Advisors
New York
$278K
T. Rowe Price Associates
67
T. Rowe Price Associates
Maryland
$278K +$11K +282 +4%
AIG
68
American International Group
New York
$275K -$19.1K -488 -7%
JP Morgan Chase
69
JP Morgan Chase
New York
$264K -$948K -24,210 -78%
GT
70
Glenmede Trust
Pennsylvania
$263K +$39.4K +1,007 +18%
SO
71
STRS Ohio
Ohio
$253K
VOYA Investment Management
72
VOYA Investment Management
Georgia
$253K +$14.7K +375 +6%
BTWM
73
Baker Tilly Wealth Management
Wisconsin
$250K +$247K +6,311 New
TI
74
Trexquant Investment
Connecticut
$246K -$3.95K -101 -2%
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$242K -$60.5K -1,545 -20%

NRC Hedge Fund Activity: Q1 2022 in Review

116 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q1 2022, worth a combined $456M — down 3.6% from $473M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new NRC positions and 13 closed out — a net gain of 4 holders — while 43 added to existing stakes and 31 trimmed.

The largest buyer was QV Investors, opening a new position worth an estimated $18.1M. The largest seller was Neuberger Berman Group, cutting an estimated $19.8M.

  • 116 institutional investors held NRC Health Common Stock (NRC) as of Q1 2022, up from 113 in Q4 2021.
  • Funds reported $456M of NRC Health Common Stock stock for Q1 2022, down 3.6% quarter-over-quarter.
  • 17 funds opened new NRC Health Common Stock positions in Q1 2022 and 13 closed out, a net change of +4 holders.
  • The largest NRC Health Common Stock buyer in Q1 2022 was QV Investors, an estimated $18.1M added.
  • The largest NRC Health Common Stock seller in Q1 2022 was Neuberger Berman Group, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2022.